Biomolecules that respond to different external stimuli enable the remote control of genetically 25 modified cells. Chemogenetics and optogenetics, two tools that can control cellular activities 26 via synthetic chemicals or photons, respectively, have been widely used to elucidate underlying 27 physiological processes. These methods are, however, very invasive, have poor penetrability, 28 or low spatiotemporal precision, attributes that hinder their use in therapeutic applications. We 29 report herein a sonogenetic approach that can manipulate target cell activities by focused 30 ultrasound stimulation. This system requires an ultrasound-responsive protein derived from an 31 engineered auditory-sensing protein prestin. Heterogeneous expression of mouse prestin 32 containing two parallel amino acid substitutions, N7T and N308S, that frequently exist in 33 prestins from echolocating species endowed transfected mammalian cells with the ability to 34 sense ultrasound. An ultrasound pulse of low frequency and low pressure efficiently evoked 35 cellular calcium responses after transfecting with prestin(N7T, N308S). Moreover, pulsed 36 ultrasound can also non-invasively stimulate target neurons expressing prestin(N7T, N308S) 37 in deep regions of mice brains. Our study delineates how an engineered auditory-sensing 38 protein can cause mammalian cells to sense ultrasound stimulation. Moreover, owing to the 39 great penetration of low-frequency ultrasound (~400 mm in depth), our sonogenetic tools will 40 serve as new strategies for non-invasive therapy in deep tissues of large animals like primates. 41 42 43 44 45 46
3

Introduction 47
Approaches that can non-invasively stimulate target cells buried in the deep tissues are 48 highly desirable for basic research and clinical therapy. Currently, different external stimuli 49 including photons, chemicals, radio waves, and magnetic fields have been used to stimulate 50 target cells implanted with stimulus-responsive proteins or nanoparticles 1-4 . However, these 51 strategies suffer from several drawbacks including invasiveness, poor spatiotemporal precision, 52 or low penetration depth, which greatly hinder their potential use in clinical therapy. To 53 overcome these long-standing problems, we aim to use focused ultrasound (FUS) as a stimulus 54 to remotely control cellular activities because it can non-invasively deliver acoustic energy to 55 deep tissues while retaining spatiotemporal coherence 5 . 56
Ultrasound waves have frequencies greater than those of sound waves that can be heard 57 by humans (>20 kHz). Low-frequency ultrasound waves (<3.5 MHz) are easily transmitted 58 through tissues, including those of bones and brains 6 . Owing to its deep penetrability and 59 spatiotemporal resolution (a few cubic millimetres), ultrasound-based neuromodulation has 60 been tested on cultured neuronal cells and in brains of various model organisms [6] [7] [8] [9] [10] [11] . As 61 continuous ultrasound waves or pulsed ultrasound waves of high acoustic pressure are typically 62 needed to activate neurons, neuronal cells are likely to be weakly sensitive to ultrasound 63 stimulus 8,12,13 . To overcome this, gas-filled microbubbles (MBs) that vibrate upon ultrasound 64 excitation have been used as ultrasound amplifiers to enhance their mechanical effects on target 65 cells 14, 15 . Recently, lbsen and colleagues used MBs to transduce mechanical stimulation from 66 ultrasound waves to neuronal cells in Caenorhabditis elegans and induced behavioural output 16 . 67
The pore-forming cationic mechanotransduction ion channel TRP-4 may be involved in 68 transducing ultrasound stimulation onto MBs attached to C. elegans 16 . Although this study 69 4 verified that ultrasound-mediated neuromodulation is possible, its further development faces 70 major roadblocks, i.e.,, MBs have a short lifespan in vivo (<5 min in the blood), and it is 71 difficult to deliver MBs to extravascular tissues 17 . Compared with MBs, gas-filled protein 72 complexes, denoted as gas vesicles, are highly stable both in vitro and in vivo and efficiently 73 oscillate in response to ultrasound excitation. Different gas vesicle variants can serve as 74 genetically encoded ultrasound contrast reagents to track target microbes or cells by ultrasound 75 imaging 18, 19 . However, it is still challenging to express and assemble prokaryotic gas vesicles 76 in mammalian cells 5 . Recently, several groups implanted mechanosensitive ion channels, such 77
as Mscl and Piezo1, into in vitro cell culture systems and, with their use, successfully perturbed 78 the cellular membrane potentials of target cells using ultrasound. 20,21 However, the ultrasound 79 frequencies used in those studies are too high (30 MHz and 43 MHz) to be applicable for in 80 vivo use owing to their low penetrability (<5 mm). Therefore, to date, there has been no 81 sonogenetic system that uses low-frequency and low-pressure ultrasound to remotely control 82 activities of mammalian cells that have been genetically modified. 83
Several mammalian species, including bats and cetaceans, use ultrasound to navigate 84 or communicate. The high-frequency auditory sensitivity and selectivity in echolocating 85 mammals have been attributed to adaptive mechanical amplification in the outer hair cells 86 (OHCs) of their cochlea 22 . Prestin (also known as SCL26A5) is a transmembrane protein 87 residing in OHCs that drives their electromotility and seems to be involved in the ability to 88 hear ultrasound [23] [24] [25] . Heterologous expression of prestin endows transfected mammalian cell 89 lines with several of the physiological hallmarks of OHCs, suggesting that prestin may 90 inherently act as an electromechanical transducer 26 . Evolutionary analysis also suggests that 91 prestin is involved in ultrasound sensing of echolocating mammals 23 . The primary sequence of 92 5 prestin is largely conserved among various mammalian species, although several specific 93 amino acid substitutions that directly affect the electromotility capacity of prestin frequently 94 occur in prestins of sonar mammals but not in those of their non-sonar counterparts 23,24 . Thus 95 prestin probably enhances ultrasound sensitivity in mammals, although how it does so is still 96 unclear. 97
98
Results and discussion 99
Here we first examined the amino acid sequences of prestin from six non-echolocating 100 species and eight echolocating species. Asn at positions 7 and 308 in prestins of non-101 echolocating species is frequently replaced with Thr and Ser, respectively, in echolocating 102 species (Fig. 1a ). To test whether these apparently evolutionarily driven amino acid 103 substitutions are important to adaptive ultrasound sensing, two mutations N7T and/or N308S 104 were introduced into mouse prestin (hereafter mPrestin). The constructs used for our study 105 were wild-type prestin (mPrestinWT); mPrestin mutants containing a single substitution, 106 mPrestin(N7T) and mPrestin(N308S); and a mutant containing two substitutions, 107 mPrestin(N7T, N308S). Each of these constructs was tagged with the yellow fluorescent 108 protein Venus. Each construct was co-transfected with the calcium biosensor cyan fluorescence 109 protein (CFP)-R-GECO into the human HEK293T cell line. The calcium influx of transfected 110 cells was used as a readout in response to the mechanical stimulation of ultrasound wave. To 111 simultaneously excite FUS and acquire real-time cell images, an ultrasound transducer 112 connected to a waveform generator and an amplifier was placed on top of the live-cell imaging 113 system. This system focuses ultrasound waves to a circle with a diameter of a few millimetres 114 over a monolayer of cultured cells (Extended Data Fig. 1 ). Using this ultrasound-imaging 115 6 system, we stimulated cells co-expressing CFP-R-GECO and Venus-mPrestin(N7T, N308S) or 116 co-expressing CFP-RGECO and Venus with a short, low-frequency ultrasound pulse (0.5 MHz, 117 all pulses consisted of 3-sec duration, 2000 cycles, 10 Hz, 0.5 MPa unless otherwise noted). 118
Live-cell imaging showed that a short ultrasound pulse of 0.5 MHz was sufficient to evoke 119 calcium influx in cells expressing Venus-mPrestin(N7T, N308S), but not in cells transfected 120 with Venus alone ( To determine the optimal ultrasound frequency/frequencies for cell manipulation, we 130 next comprehensively tested the calcium responses of cells expressing the various Venus-131 mPrestin constructs to different FUS frequencies between 80 kHz and 3.5 MHz (3-sec duration, 132 2000 cycles, 0.5 MPa; Fig. 2 ). Interestingly, cells individually expressing the WT and mutated 133 constructs were sensitive only to 0.5 MHz FUS (Fig. 2) . The 80 kHz, 1 MHz, 2 MHz, and 3.5 134
MHz FUS were insufficient to evoke a calcium influx in the cells ( to induce a calcium response in cells expressing mTRPC4-CFP. Thus, mTRPC4-CFP is 153 only weakly sensitive to 0.5 MHz FUS. Although its protein sequence is very similar to 154 that of mTRPC4, hTRPC4-CFP did not respond to the low-frequency ultrasound 155 stimulation at all (Extended Data Fig. 2 ). Taken together, the comprehensive examination 156 of ultrasound sensing in cells transfected with different putative ultrasound-responsive 157 proteins shows that mPrestin(N7T, N308S) was the most responsive protein. We next explored the possible molecular mechanisms that make the two 159 evolutionarily conserved amino acid substitutions important for prestin-dependent 160 ultrasound sensing. Targeting of prestin to the plasma membrane is required for its 161 8 function 29 . Confocal images of Venus-mPrestinWT and Venus-mPrestin(N7T, N308S) in 162 living cells showed that Venus-mPrestinWT localised to the cytosol and to the plasma 163 membrane, whereas Venus-mPrestin(N7T, N308S) localised exclusively to the plasma 164 membrane ( Fig. 3a) . Quantification of the relative intensities confirmed that 165 mPrestin(N7T, N308S) exhibited a significantly greater plasma membrane/cytosol 166 intensity ratio than did Venus-mPrestinWT (p = 0.003; Fig. 3b ). We therefore 167 hypothesised that targeting mPrestin(N7T, N308S) to the plasma membrane is important 168 for its sensitivity to ultrasound. To assess this hypothesis, we introduced a point mutation 169 (Y667Q) that causes prestin to mislocate to the Golgi apparatus into Venus-170 mPrestin(N7T, N308S). As expected, Venus-mPrestin(N7T, N308S, Y667Q) accumulated 171 at the Golgi apparatus, and its plasma membrane/cytosol intensity ratio decreased 172 significantly (p = 1.02E-7; Fig. 3a, b ). The mislocalisation of Venus-mPrestin(N7T, N308S, 173 Y667Q) to the Golgi apparatus impaired its ultrasound-sensing ability (p = 0.032; Fig. 3c ), 174
confirming that plasma-membrane targeting of Venus-mPrestin(N7T, N308S) is required 175 for its response to ultrasound. We next determined in which cellular compartment the calcium is stored that is 210 released by Venus-mPrestin(N7T, N308S) upon FUS stimulation. Addition of the calcium 211 chelator ethylene glycol tetraacetic acid (EGTA) in the extracellular space completely 212 inhibited the calcium response in cells expressing Venus-mPrestin(N7T, N308S) upon 213 ultrasound stimulation (p = 6.2E-7; Fig. 3f ). However, depletion of the intracellular 214 calcium store by thapsigargin did not significantly affect the ultrasound-mediated 215 calcium response (p = 0.16; Fig. 3f ). Thus mPrestin(NT7, N308S) induced calcium influx 216 from the extracellular space instead of from the intracellular calcium pool after FUS 217 excitation. We speculate that replacement of Asn with Thr and Ser at positions 7 and 308, 218 respectively, in mPrestin enhanced its localisation to the plasma membrane where its 219 oscillations promoted calcium influx from the extracellular pool. 220
Several mechanosensitive ion channels are activated by high-frequency 221 ultrasound 20,21 . We incubated gentamicin, a pharmaceutical inhibitor of 222 mechanosensitive ion channels, with cells that expressed Venus-mPrestin(N7T, N308S) 33 223 and found that this treatment did not significantly affect the calcium response upon 224 ultrasound excitation (p = 0.27; Fig. 3f ). Thus gentamicin-sensitive ion channels were not 225 involved in the mPrestin(N7T, N308S)-mediated calcium response, which is consistent 226 with results from an ultrasound-inducible system driven by piezoelectric nanoparticles 34 . 227
Ultrasound excites neuronal cells by activating voltage-gated ion channels 6 . To examine 228 the possible involvement of voltage-gated ion channels in our system, cells expressing 229
Venus-mPrestin(N7T, N308S) were incubated with tetrodotoxin (TTX), an inhibitor of 230 11 voltage-gated ion channels, and then stimulated with 0.5 MHz FUS. However, the 231 percentage of ultrasound-excitable cells transfected with mPrestin(N7T, N308S) was not 232 affected by TTX treatment, indicating that voltage-gated ion channels are not involved in 233 the mPrestin-mediated pathway (p = 0.80; Fig. 3f ). 234
To take advantage of the great sensitivity of Venus-mPrestin(N7T, N308S) to 235 ultrasound stimulation, we next developed a sonogenetic system that would allow for 236 stimulating neurons (Fig. 4) . Infection of primary cultured cortical neurons with a Venus-237 mPrestin(N7T, N308S)-containing lentivirus led to the expression of Venus-238 mPrestin(N7T, N308S) on a neuronal membrane. Moreover, Venus-mPrestin(N7T, 239 N308S) also forms puncta on neuronal membrane (Fig. 4a ). For the sonogenetic 240 stimulation of target neurons in deep brain, an adeno-associated virus (AAV) encoding 241
Venus-mPrestin(N7T, N308S) or Venus alone was injected into the VTA brain region. 242
Two weeks later, anesthetized mice were exposed to transcranial pulsed ultrasonic 243 excitation (0.5 MHz FUS, 0.5 MPa, 5 seconds; Fig. 4b ). FUS-activated neurons were 244 mapped by imaging the expression of c-Fos (Fig. 4c ). Neuronal excitation was triggered 245 by a short pulsed FUS in Venus-mPrestin(N7T, N308S)-transfected mice (p = 8.64E-3, 246 Fig. 4c,d ). Control mice with Venus alone expression showed no significant c-Fos 247 expression in VTA region (p = 0.08, Fig. 4c,d) . These results demonstrated that 248 mPrestin(N7T, N308S)-mediated sonogenetics is a flexible and non-invasive approach 249 for sonogenetic control of neuronal activity. 250
In summary, we here have introduced two evolutionarily conserved amino acid 251 substitutions N7T and N308S into mouse prestin which enhances its self-association as 252 well as puncta formation in the plasma membrane. These mPrestin(N7T, N308S) puncta 253 12 highly associate with actin filaments and microtubules in cells. A short pulse of 0.5 MHz 254 FUS induces sustained oscillation of mPrestin(N7T, N308S) puncta with electromotility 255 and evokes several waves of calcium responses in transfected cells (Extended Data Fig.  256   4) . The ultrahigh ultrasound sensitivity of mPrestin(N7T, N308S) allows for non-257 invasively stimulation of target neurons in deep mice brain by a short pulsed FUS. 258
Our results raised a fundamental question: why are mPrestin(N7T, N308S)-259 transfected cells sensitive only to ultrasound of 0.5 MHz? Because we used a short, low-260 frequency, and low-pressure ultrasound pulse of constant acoustic power (0.5 MPa), it is 261 unlikely that any unexpected thermal and/or mechanical effects were present that would 262 restrict the frequency to 0.5 MHz. We therefore assume that a frequency of 0.5 MHz is 263 simply optimal for stimulation of cells. Cell membranes are able to absorb ultrasound are the optimal frequencies of ultrasound for inducing intramembrane cavitation as well 267 as bio-piezoelectric perturbation 7,36 . Because prestin acts as a piezoelectric amplifier to 268 enhance the electromotile response in OHCs and mammalian cell lines 25,26 , we suggest 269 that the ultrasound-induced intramembrane bio-piezoelectric perturbation may be 270 amplified by mPrestin(N7T, N308S) that then trigger the observed calcium influx. 271
Ultrasound of 80 kHz, which is the peak frequency used by most sonar species 23 , did not 272 efficiently induce a calcium response in Venus-mPrestin(N7T, N308S)−transfected cells 273 ( Fig. 2) , which suggested that the mechanism(s) of how sonar-responsive species hear 274 ultrasound by auditory organs may not be the same as in our system. 275
Similar to photon-responsive-proteins and fluorescent proteins, which absorb 276 13 distinct wavelengths of light and allow for multiplex imaging and optogenetics, 277 mPrestin(N7T, N308S) specifically responds to 0.5 MHz FUS, suggesting that a multiple-278 frequency system using ultrasound of 1-15 MHz can be developed to non-invasively 279 diagnose regions of abnormal tissues and simultaneously manipulate cellular activities 280 with 0.5 MHz FUS. Moreover, because 0.5 MHz FUS waves cannot be delivered through 281 the air and are rarely used by sonar species, the natural background level for this 282 frequency is expected to be low. Previously developed simulations and experimental data 283 suggest that ultrasound wavelengths of ~0.60−0.70 MHz would be optimal for 284 transcranial transmission and brain absorption 37,38 , supporting that our sonogenetic 285 system is a promising tool for therapeutic applications involving the brain. Indeed, our in 286 vivo results showed that 0.5 MHz FUS efficiently accesses to the deep brain regions like 287 VTA and stimulates target neurons expressing Venus-mPrestin(N7T, N308S) ( Fig. 4c,d) . 288
To our knowledge, this mPrestin(N7T, N308S)-based sonogenetic approach is the 289 first system that enables the use of low-frequency ultrasound to efficiently manipulate 290 molecular activities in mammalian cells that are genetically modified. Although 291 heterogeneous expression of mPrestin(N7T, N308S) significantly enhanced the 292 ultrasound sensitivity of HEK293T cells (p = 0.0046, 10.18 ± 2.90% for the Venus-293 mPrestin(N7T, N308S) group; 1.33 ± 0.42% for the Venus-alone group; combined data 294 shown in Figs. 1d and 2f) , the percentage of ultrasound-excitable cells in our system 295 
Immunohistochemistry staining (IHC) 416
The successful stimulation of mPrestin(N7T, N308S)-transfected cells was verified by c-417
Fos IHC staining. 39 The brains of mice were removed were sacrificed at 90 min after 0.5 MHz 418 FUS stimulation. The brains were then sliced into 15-μm sections and incubated into 5% goat 419 serum and PBS for 1 h to block the endogenous proteins. The sections were then incubated in 420 primary rabbit anti-c-Fos antibody (1:1000; SYSY) in antibody diluent for overnight. The 
